Oliver Schacht, CEO of OPGN, Speaks to StoryTrading About OpGen and Molecular Diagnostics

Oliver Schacht, the CEO of OpGen Inc (NASDAQ: OPGN) talks about their current product line and a push into molecular diagnostics. Watch now to learn more about OPGN directly from management.

----------------

Recorded June 23rd, 2021. VIP members get exclusive early access to most events including access to the full recordings with the Q&A session. Become a VIP member and view Q&A sessions and exclusive content: https://storytrading.com/vip-upgrade/

Check out StoryTrading here: https://www.storytrading.com/​

You can learn more about OPGN here: https://www.opgen.com/

Disclaimer:
StoryTrading is not a registered investment advisor. Anything said in the video is for informational, educational, and entertainment purposes only and should not be considered as investment advice or a recommendation to invest in any particular security, strategy, or investment product. Investing in securities involves significant risk of loss. Past performance is no indication or guarantee of future results and the value of any investment you make may go up or down.

Visit our website to view our full disclaimer. https://www.storytrading.com/disclaimer/